4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-034069
Options or other derivatives
- Director acquired 250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KING STEVEN W · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-10 | Grant or award : show line 1 in the form Restricted stock Units | +250 | 250 | D |
Loading xslF345X06/ownership.xml…